Shin Nishio

Summary

Affiliation: Kurume University School of Medicine
Country: Japan

Publications

  1. ncbi Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia
    Shin Nishio
    Department of Basic Pathology, National Defense Medical College, 3 2 Namiki, Tokorozawa, Saitama 359 8513, Japan
    Pathol Res Pract 205:331-7. 2009
  2. ncbi Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
    Cancer Lett 264:36-43. 2008
  3. ncbi Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy
    Shin Nishio
    Division of Medical Oncology, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo, 104 0045, Japan
    J Cancer Res Clin Oncol 135:551-7. 2009
  4. ncbi [A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer]
    Shin Nishio
    Division of Medical Oncology, National Cancer Center Hospital
    Gan To Kagaku Ryoho 33:1589-93. 2006
  5. ncbi Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma
    Shin Nishio
    Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
    Oncol Rep 19:497-503. 2008
  6. ncbi Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum- and taxane-resistant epithelial ovarian cancer
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka Pretecture, 830 0011, Japan
    Gynecol Oncol 106:342-7. 2007
  7. ncbi Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan
    J Obstet Gynaecol Res 32:416-21. 2006
  8. ncbi Polypoid endocervical adenomyoma: a case report with clinicopathologic analyses
    Shunichiro Ota
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan
    J Obstet Gynaecol Res 33:363-7. 2007
  9. ncbi Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
    Kimio Ushijima
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan
    J Gynecol Oncol 24:108-13. 2013
  10. ncbi Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahi Machi, Kurume 830 0011, Japan
    Int J Clin Oncol 8:45-8. 2003

Detail Information

Publications10

  1. ncbi Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia
    Shin Nishio
    Department of Basic Pathology, National Defense Medical College, 3 2 Namiki, Tokorozawa, Saitama 359 8513, Japan
    Pathol Res Pract 205:331-7. 2009
    ..LEGH may be one of the factors related to the development of cervical adenocarcinoma, but adenocarcinoma with LEGH components does not necessarily develop into a highly aggressive "adenoma malignum."..
  2. ncbi Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
    Cancer Lett 264:36-43. 2008
    ..Our results suggest that increased expression of Cap43 is associated with angiogenesis and may be a poor prognostic indicator in women with cervical adenocarcinoma...
  3. ncbi Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy
    Shin Nishio
    Division of Medical Oncology, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo, 104 0045, Japan
    J Cancer Res Clin Oncol 135:551-7. 2009
    ..Limited information is available regarding the usefulness of third-line chemotherapy for recurrent ovarian, fallopian tube, and primary peritoneal cancer treated with platinum-taxane regimens as first-line therapy...
  4. ncbi [A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer]
    Shin Nishio
    Division of Medical Oncology, National Cancer Center Hospital
    Gan To Kagaku Ryoho 33:1589-93. 2006
    ..No grade 3/4 cardiac and renal failure were observed. CONCLUSIONS: The doxorubicin/cisplatin (AP) regimen is tolerated and can be safely given without severe toxicity...
  5. ncbi Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma
    Shin Nishio
    Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
    Oncol Rep 19:497-503. 2008
    ..03) were independent prognostic factors of survival, respectively. Poor PS and non-chemotherapy groups were found to have poor prognosis in patients with stage IVb CC. Chemotherapy may improve the survival for stage IVb CC...
  6. ncbi Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum- and taxane-resistant epithelial ovarian cancer
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka Pretecture, 830 0011, Japan
    Gynecol Oncol 106:342-7. 2007
    ..To evaluate the efficacy and toxicity of combination chemotherapy with intravenous irinotecan and oral etoposide in women with platinum- and taxane-resistant epithelial ovarian cancer...
  7. ncbi Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan
    J Obstet Gynaecol Res 32:416-21. 2006
    ..The aim of this study was to investigate whether fertility preservation influences the clinical outcome in patients with malignant germ cell tumors of the ovary (MGCTO)...
  8. ncbi Polypoid endocervical adenomyoma: a case report with clinicopathologic analyses
    Shunichiro Ota
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan
    J Obstet Gynaecol Res 33:363-7. 2007
    ..Therefore, the results of these ancillary diagnostic modalities should be interpreted with caution and combined with the gross and light microscopy findings...
  9. ncbi Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
    Kimio Ushijima
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan
    J Gynecol Oncol 24:108-13. 2013
    ..To evaluate the clinical efficacy of concurrent chemoradiotherapy (CCRT) using daily low-dose cisplatin for cervical cancer...
  10. ncbi Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahi Machi, Kurume 830 0011, Japan
    Int J Clin Oncol 8:45-8. 2003
    ..The aim of this study was to evaluate the toxicity and efficacy of weekly paclitaxel in patients with recurrent endometrial cancer...